MRPI — Mera Pharmaceuticals Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Mera Pharmaceuticals, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2007 October 31st	2008 October 31st	R2009 October 31st	2010 October 31st	2011 October 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB/A	10KSB	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.47	0.61	0.599	0.289	0.303
Cost of Revenue
Gross Profit	0.411	0.571	0.571	0.243	0.286
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	0.801	2.59	0.821	0.841	0.504
Operating Profit	-0.331	-1.98	-0.222	-0.552	-0.201
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.338	-1.98	-0.224	-0.557	-0.202
Provision for Income Taxes
Net Income After Taxes	-0.321	-1.95	-0.193	-0.538	-0.188
Net Income Before Extraordinary Items
Net Income	-0.321	-1.95	-0.193	-0.538	-0.188
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.321	-1.95	-0.226	-0.571	-0.221
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.001	-0.002	-0	-0.001	-0
Dividends per Share